Advanced drug therapy for juvenile rheumatoid arthritis
- 28 February 1989
- journal article
- review article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 114 (2) , 171-178
- https://doi.org/10.1016/s0022-3476(89)80780-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.BMJ, 1986
- Penicillamine and Hydroxychloroquine in the Treatment of Severe Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 1986
- CAN TREATMENT REALLY INFLUENCE THE RADIOLOGICAL PROGRESSION OF RHEUMATOID ARTHRITIS?Rheumatology, 1986
- Evaluation of d‐penicillamine in juvenile chronic arthritis. A double‐blind, multicenter studyArthritis & Rheumatism, 1985
- Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.Annals of the Rheumatic Diseases, 1985
- Gold Sodium Thiomalate and D-Penicillamine:A Controlled, Comparative Study in Patients with Pauciarticular and Polyarticular Juvenile Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1985
- SULPHASALAZINE: A ‘NEW’ ANTIRHEUMATIC DRUGRheumatology, 1984
- Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and HydroxychloroquineScandinavian Journal of Rheumatology, 1974
- The Treatment of Juvenile Rheumatoid Arthritis with AzathioprineScandinavian Journal of Rheumatology, 1972
- Comparison of the Effect of Plasmapheresis and Penicillamine on the Level of Circulating Rheumatoid FactorAnnals of the Rheumatic Diseases, 1963